U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options ...Middle East

EMBLAVEOTM is the first and only monobactam/β-lactamase inhibitor combination antibiotic therapy approved by the U.S. FDA to treat complicated intra-abdominal infections, including those caused by Gram-negative bacteria Gram-negative bacterial infections represent a significant public...

Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options )

Also on site :

• Brynn Whitfield Announces Exit From 'RHONY' After Two Seasons
• Born on One of These 4 Dates? You're a Wise, Old Soul
• Tony-Nominated Actress, 23, Makes Bold Declaration About Taylor Swift